Literature DB >> 9972682

Synthetic peptides and their non-peptidyl mimetics in endocrinology: from synthesis to clinical perspectives.

R Deghenghi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9972682     DOI： 10.1007/BF03348048

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  28 in total

1.  Somatostatin analogs: future directions.

Authors:  S W Lamberts; A J van der Lely; W W de Herder; L J Hofland
Journal:  Metabolism       Date:  1996-08       Impact factor: 8.694

2.  Topochemical investigations of peptide systems.

Authors:  M M Shemyakin; Y A Ovchinnikov; V T Ivanov
Journal:  Angew Chem Int Ed Engl       Date:  1969-07       Impact factor: 15.336

3.  On the discovery of growth hormone-releasing hormone.

Authors:  M O Thorner
Journal:  Acta Paediatr Suppl       Date:  1993-03

4.  Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

Authors:  J Rivier; J Spiess; M Thorner; W Vale
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

5.  Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Authors:  P Brazeau; W Vale; R Burgus; N Ling; M Butcher; J Rivier; R Guillemin
Journal:  Science       Date:  1973-01-05       Impact factor: 47.728

6.  Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone.

Authors:  M Zarandi; J E Horvath; G Halmos; J Pinski; A Nagy; K Groot; Z Rekasi; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone.

Authors:  J Izdebski; J Pinski; J E Horvath; G Halmos; K Groot; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.

Authors:  R Guillemin; P Brazeau; P Böhlen; F Esch; N Ling; W B Wehrenberg
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

9.  A receptor in pituitary and hypothalamus that functions in growth hormone release.

Authors:  A D Howard; S D Feighner; D F Cully; J P Arena; P A Liberator; C I Rosenblum; M Hamelin; D L Hreniuk; O C Palyha; J Anderson; P S Paress; C Diaz; M Chou; K K Liu; K K McKee; S S Pong; L Y Chaung; A Elbrecht; M Dashkevicz; R Heavens; M Rigby; D J Sirinathsinghji; D C Dean; D G Melillo; A A Patchett; R Nargund; P R Griffin; J A DeMartino; S K Gupta; J M Schaeffer; R G Smith; L H Van der Ploeg
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

Review 10.  Somatostatin receptors and disease: role of receptor subtypes.

Authors:  L J Hofland; S W Lamberts
Journal:  Baillieres Clin Endocrinol Metab       Date:  1996-01
View more
  2 in total

1.  Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans.

Authors:  E Arvat; L Di Vito; F Broglio; M Papotti; G Muccioli; C Dieguez; F F Casanueva; R Deghenghi; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction.

Authors:  Hayley McDonald; Jason Peart; Nyoman Kurniawan; Graham Galloway; Simon Royce; Chrishan S Samuel; Chen Chen
Journal:  Physiol Rep       Date:  2018-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.